Exchange Traded Concepts, LLC I Teos Therapeutics, Inc. Transaction History
Exchange Traded Concepts, LLC
- $5.43 Billion
- Q1 2025
A detailed history of Exchange Traded Concepts, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 17,308 shares of ITOS stock, worth $112,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,308
Previous 13,840
25.06%
Holding current value
$112,675
Previous $106,000
2.83%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ITOS
# of Institutions
148Shares Held
33.3MCall Options Held
454KPut Options Held
2.45M-
Black Rock Inc. New York, NY3.73MShares$24.3 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$17.8 Million16.91% of portfolio
-
Bvf Inc San Francisco, CA2.33MShares$15.1 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.09MShares$13.6 Million0.26% of portfolio
-
Jpmorgan Chase & CO New York, NY2.07MShares$13.5 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $232M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...